Agile Therapeutics, Inc. (AGRX)
NASDAQ: AGRX · IEX Real-Time Price · USD
1.95
+0.03 (1.56%)
At close: Dec 29, 2023, 4:00 PM
1.92
-0.03 (-1.54%)
After-hours: Dec 29, 2023, 6:55 PM EST
Agile Therapeutics Stock Forecast
Stock Price Forecast
According to 2 stock analysts, the average 12-month stock price forecast for AGRX stock stock is $8.50, which predicts an increase of 335.90%. The lowest target is $5.00 and the highest is $12. On average, analysts rate AGRX stock stock as a strong buy.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 22, 2023.
Analyst Ratings
The average analyst rating for AGRX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $5 | Hold → Strong Buy | Upgrades | $5 | +156.41% | Sep 22, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +515.38% | Jun 26, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +515.38% | Jun 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $250 → $150 | Strong Buy | Maintains | $250 → $150 | +7,592.31% | Dec 30, 2022 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +2,464.10% | Jul 26, 2022 |
Financial Forecast
Revenue This Year
25.79M
from 10.88M
Increased by 136.94%
Revenue Next Year
43.72M
from 25.79M
Increased by 69.51%
EPS This Year
-7.75
from -59.00
EPS Next Year
0.67
from -7.75
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 26.5M | 45.0M | 62.3M | 91.9M | 131.6M | 168.5M |
| Avg | 25.8M | 43.7M | 60.5M | 83.3M | 112.1M | 163.7M |
| Low | 24.8M | 42.0M | 58.2M | 74.3M | 92.6M | 157.3M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 143.9% | 74.5% | 42.5% | 51.8% | 58.0% | 50.3% |
| Avg | 136.9% | 69.5% | 38.5% | 37.6% | 34.6% | 46.0% |
| Low | 127.6% | 62.9% | 33.0% | 22.7% | 11.2% | 40.3% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -7.98 | 0.69 | 1.74 | 1.48 | 2.66 |
| Avg | -7.75 | 0.67 | 1.69 | 1.44 | 2.58 |
| Low | -7.45 | 0.65 | 1.63 | 1.38 | 2.48 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | 158.9% | -12.6% | 84.7% |
| Avg | - | - | 151.5% | -15.1% | 79.4% |
| Low | - | - | 141.7% | -18.4% | 72.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.